Selectquote Inc Stock Price, News & Analysis

SelectQuote (NYSE: SLQT) released Healthcare Select research dated October 15, 2025 revealing access and adherence gaps among tens of thousands of Medicare-eligible members. Key findings: 45% live in rural ZIPs, 36% in urban, 74% have two or more chronic conditions, 75% take 5+ prescriptions, and 77% report household income under $20,000. The report also found ~66% reside in pharmacy deserts, 40% report medication non-adherence, and 31% lack reliable transportation. SelectQuote positions its Healthcare Select and SelectRx models as telephonic, coordinated solutions and is seeking partners to address these gaps.

SelectQuote (NYSE: SLQT) has achieved a significant milestone in its partnership with Findhelp, successfully directing over 200,000 low-income seniors to social services, with nearly 50,000 receiving vital assistance. The collaboration focuses on addressing Social Determinants of Health (SDoH) by connecting seniors with essential resources including food assistance, housing support, transportation, healthcare, and financial aid.

Through Findhelp's comprehensive platform, SelectQuote extends its services beyond traditional Medicare insurance distribution to provide holistic support for seniors' well-being. The partnership represents a key component of SelectQuote's mission to deliver comprehensive healthcare solutions through its three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life.

SelectQuote (NYSE:SLQT) reported Q4 FY2025 consolidated revenue of $345.1 million, up from $307.2 million in Q4 FY2024. The company posted net income of $12.9 million, compared to a net loss of $31.0 million in the prior year period. Adjusted EBITDA was $2.7 million, down from $14.4 million year-over-year.

The company's Healthcare Services segment showed strong growth with revenue of $214.0 million, up 47% year-over-year, while SelectRx members increased 31% to 108,018. The Senior segment revenue declined 28% to $82.5 million, with Medicare Advantage approved policies decreasing 20% to 85,344.

For FY2026, SelectQuote guides revenue between $1.65-1.75 billion and Adjusted EBITDA of $120-150 million.

SelectQuote (NYSE:SLQT) reported Q4 FY2025 results with consolidated revenue of $345.1 million, up from $307.2 million in Q4 FY2024. The company achieved net income of $12.9 million, a significant improvement from a $31.0 million loss in the prior year period, though Adjusted EBITDA decreased to $2.7 million from $14.4 million.

The company's performance was driven by three segments: Senior ($82.5M revenue), Healthcare Services ($214.0M revenue), and Life ($48.0M revenue). Healthcare Services showed strong growth with SelectRx members increasing 31% to 108,018. For FY2026, SelectQuote projects revenue between $1.65-1.75 billion and Adjusted EBITDA of $120-150 million.

SelectQuote (NYSE:SLQT), a leading Medicare insurance policy distributor and healthcare services platform provider, has scheduled its fiscal fourth quarter and full year 2025 earnings release for August 21, 2025, before market open.

CEO Tim Danker and CFO Ryan Clement will host a conference call at 8:30 am ET on the same day to discuss the results. Interested parties can register for the call through a provided link, with registration remaining open through the live call. The event will also be available via webcast on the company's investor relations website.

SelectQuote (NYSE:SLQT) announced the expanded launch of a new concierge-like service through its SelectRx pharmacy, designed to improve medication adherence for Medicare beneficiaries with multiple chronic conditions. A recent trial with a regional health plan demonstrated over 90% adherence, enhancing HEDIS Star ratings across triple-weighted measures for cholesterol, diabetes, and hypertension.

The program identifies high and medium-risk patients prone to adherence gaps, offering enhanced support through a clinical pharmacist team. The Company plans to expand to additional payers in 2025 and implement the program across SelectRx's pharmacy platform in 2026, reinforcing SelectQuote's evolution beyond traditional Medicare brokerage.

SelectQuote (NYSE:SLQT) announced the passing of William Thomas (Tom) Grant II, Vice Chairman and former President, on July 1, 2025. Grant played a crucial role in transforming SelectQuote from a term life insurance brokerage into a diversified insurance and healthcare services business over the past 15 years.

His sons, Bill Grant and Bob Grant, will continue their executive roles as Chief Operating Officer and President, respectively. SelectQuote, founded in 1985, operates through three core business lines: SelectQuote Senior for Medicare plans, SelectQuote Healthcare Services including SelectRx Pharmacy, and SelectQuote Life.

SelectQuote (NYSE: SLQT), a leading Medicare insurance policy distributor, has achieved a Net Promoter Score (NPS) of 58, categorized as "Great" by industry standards. The company was also recently included in USA Today's "America's Best Customer Service" list for 2025. The NPS score reflects high customer satisfaction, measuring the difference between "promoters" (scores 9-10) and "detractors" (scores 1-6).

Founded in 1985, SelectQuote operates through three core business lines: SelectQuote Senior (Medicare plans), SelectQuote Healthcare Services (including SelectRx Pharmacy and chronic care management), and SelectQuote Life. The company serves approximately 10,000 people turning 65 each day with Medicare Advantage and Medicare Supplement plans through its highly-trained agents and proprietary technology.

SelectQuote (NYSE: SLQT) reported its Q3 FY2025 results with consolidated revenue of $408.2 million, up from $376.4 million in Q3 FY2024. Net income reached $26.0 million, a significant increase from $8.6 million year-over-year, while Adjusted EBITDA was $37.7 million compared to $46.6 million in Q3 FY2024. The company's performance was driven by strong execution across segments: Senior generated revenue of $169.4 million with 168,001 approved Medicare Advantage policies, Healthcare Services achieved revenue of $189.6 million with 105,523 SelectRx members (41% YoY growth), and Life segment revenue reached $45.8 million. For FY2025, SelectQuote expects revenue between $1.500-$1.575 billion and net income ranging from $(1) million to $28 million.